Advertisement

Survival of patients with SLE admitted to an intensive care unit—a retrospective study

  • 184 Accesses

  • 19 Citations

Abstract

We examined the demography, reasons for admission and cause of death in systemic lupus erythematosus (SLE) patients admitted to a medical intensive care unit (ICU) over a 7-year period. Fourteen patients were admitted during this period—all were female, 13 were of mixed ethnic ancestry and one a black South African. Of the 14 patients, 12 were admitted as a result of lupus activity, 2 had sepsis as the major cause of admission, although 5 other patients developed infection during their admission. Five patients had a generalised flare of their disease or progressive renal failure. Seven patients were admitted with a variety of lupus-related pathologies. In general the precise cause of death was difficult to determine. Of the 14 patients, 9 had impaired renal function on admission including 1 with sepsis and 1 of the survivors. Three patients (21%) survived, one with respiratory failure due to shrinking lung, a second with an acute flare of SLE and a third with pulmonary emboli. This study demonstrates that lupus in our community may produce life-threatening flares. Although cause of death was not always definitely identified, admission to the ICU was primarily due to active SLE and not sepsis or iatrogenic disease.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

References

  1. 1.

    Klippel JH (1997) Systemic lupus erythematosus: demographics, prognosis and outcome. J Rheumatol 24 [Suppl 48]:67–71

  2. 2.

    Uramoto KM, Michet CJ, Thumbo J et al (1999) Trends in the incidence and mortality of systemic lupus erythematosus 1950–1992. Arthritis Rheum 42:46–50

  3. 3.

    Ginzler EM, Schorn K (1988) Outcome and prognosis in systemic lupus erythematosus. Rheum Dis Clin North Am 14:67–78

  4. 4.

    Gladman DD, Urowitz MB (1987) Morbidity in systemic lupus erythematosus. J Rheumatol 14 [Suppl 13]:223–226

  5. 5.

    Godeau B, Mortier E, Roy PM et al (1997) Short and long term outcomes for patients with systemic rheumatic diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 24:1317–1323

  6. 6.

    Ansell SM, Bedhesi S, Ruff B et al (1996) Study of critically ill patients with systemic lupus erythematosus. Crit Care Med 24:981–984

  7. 7.

    Williams FMK, Chinn S, Hughes GRV, Leach RM (2002) Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis 61:414–421

  8. 8.

    Studenski S, Allen NB, Caldwell DS et al (1987) Survival in systemic lupus erythematosus. Arthritis Rheum 30:1326–1332

  9. 9.

    Paton NIJ, Cheong IKS, Kong NCT et al (1996) Risk factors for infection in Malaysian patients with systemic lupus erythematosus. Q J Med 89:531–538

  10. 10.

    Cohen MG, Li EK (1992) Mortality in systemic lupus erythematosus: active disease is the most important factor. Aust N Z J Med 22:5–8

  11. 11.

    Rosner S, Ginzler EM, Diamond HS et al (1982) A multicentre study of outcome in systemic lupus erythematosus. Arthritis Rheum 25:612–617

  12. 12.

    Symmons DPM (1995) Occasional series. Lupus around the world. Frequency of lupus in people of African origin. Lupus 4:176–178

  13. 13.

    Bates WD, Halland AM, Tribe RD et al (1991) Lupus nephritis. Part I. Histopathological classification, activity and chronicity scores. S Afr Med J 79:256–259

  14. 14.

    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

  15. 15.

    Whitelaw DA, Spangenberg JJ, Rickman R et al (1999) The association between the antiphospholipid antibody syndrome and neurological impairment in SLE. Lupus 8:444–448

  16. 16.

    Raj R, Murin S, Matthay A et al (2002) Systemic lupus erythematosus in the intensive care unit. Crit Care Clin 18:781–803

  17. 17.

    Nived O, Sturfelt G, Wollheim F (1985) Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med 55:271–287

  18. 18.

    Breshninan B (1989) Outcome and survival in systemic lupus erythematosus. Ann Rheum Dis 48:443–445

  19. 19.

    Pu SJ, Luo SF, Wu YJJ et al (2000) The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus 9:96–100

  20. 20.

    Staples P, Gerding D, Decker J et al (1974) Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 17:1–10

  21. 21.

    Duffy KNW, Duffy CM, Gladman DD (1991) Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol 18:1180–1184

  22. 22.

    Jonsson H, Nived O, Sturfelt G (1989) Outcome in systemic lupus erythematosus: a prospective study in a defined population. Medicine 68:141–150

  23. 23.

    Ter Borg EJ, Horst G, Limburg PC et al (1990) C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 17:1642–1648

  24. 24.

    Morley JJ, Kushner I (1982) Serum C-reactive protein levels in disease. Ann N Y Acad Sci 389:406–418

  25. 25.

    Jansen NM, Karnad DP, Guntupalli KK (2002) Rheumatic diseases in the intensive care unit: epidemiology clinical outcome, management and outcome. Crit Care Clin 18:729–748

  26. 26.

    Esdaile JM, Abrahamowicz M, Joseph L et al (1996) Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Arthritis Rheum 39:370–378

Download references

Author information

Correspondence to D. A. Whitelaw.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Whitelaw, D.A., Gopal, R. & Freeman, V. Survival of patients with SLE admitted to an intensive care unit—a retrospective study. Clin Rheumatol 24, 223–227 (2005). https://doi.org/10.1007/s10067-004-1007-3

Download citation

Keywords

  • Flares
  • Intensive care
  • Mortality
  • Systemic lupus erythematosus